The pricey medications remain out of reach for millions of patients across the country who could benefit from them.

Jade-Olivia Patrick, 35, from London, turned to weight-loss jabs after years of dieting. Here, she shares her life-changing ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...

Image by Markus Winkler on Pexels In recent months, a surprising shift has emerged in the world of mental health. Medications ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

As drugs like Wegovy and Mounjaro continue to rise in popularity, the dieting industry has been forced to adapt. Earlier this month, WeightWatchers filed for bankruptcy in the US after struggling with ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...